
Clinical Trials PRRT: From 177Lu to 225Ac: The LM3 Antagonist Journey Toward High‑LET PRRT
Disclaimer:Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by














